AI assistant
Sending…
Predictive Oncology Inc. — Director's Dealing 2016
Sep 19, 2016
35106_dirs_2016-09-19_23538d85-5ab9-42f3-86cc-3a9e7af162ca.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Skyline Medical Inc. (SKLN)
CIK: 0001446159
Period of Report: 2016-09-16
Reporting Person: JOHNSON DAVID O. (Chief Operating Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-09-16 | Stock Options (right to buy) | $0.1679 | A | 89339 | Disposed | 2026-09-16 | Common Stock (89399) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 17302 | Direct |
Footnotes
F1: 191 shares held jointly with spouse.
More from Predictive Oncology Inc.
Capital/Financing Update
2026
Jun 9
Regulatory Filings
2026
Jun 9
Earnings Release
2026
May 15
Capital/Financing Update
2026
May 15
Capital/Financing Update
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 22
Board/Management Information
2026
Apr 16
Board/Management Information
2026
Apr 1